Timing of recombinant human granulocyte colony-stimulating factor administration on neutropenia induced by cyclophosphamide in normal mice
1998

Timing of rhG-CSF Administration on Neutropenia Induced by Cyclophosphamide in Mice

Sample size: 6 publication Evidence: moderate

Author Information

Author(s): M Misaki, Y Ueyama, G Tsukamoto, T Matsumura

Primary Institution: Okayama University Dental School, Japan

Hypothesis

Does altering the timing of rhG-CSF administration affect neutropenia induced by cyclophosphamide?

Conclusion

The timing of rhG-CSF administration significantly influences neutrophil recovery and progenitor cell kinetics after chemotherapy.

Supporting Evidence

  • Mice receiving rhG-CSF before chemotherapy showed the best recovery from neutropenia.
  • Progenitor cell counts were significantly affected by the timing of rhG-CSF administration.
  • Neutrophil counts increased more rapidly in the pre- and post-treatment group compared to the control.

Takeaway

This study shows that giving a medicine called rhG-CSF at different times can help mice recover from low white blood cell counts caused by chemotherapy.

Methodology

Mice were treated with cyclophosphamide and rhG-CSF at different times, and their neutrophil and progenitor cell counts were measured.

Limitations

The study was conducted on mice, which may not fully represent human responses.

Participant Demographics

Female C57BL mice, aged 8-10 weeks.

Statistical Information

P-Value

p<0.01

Statistical Significance

p<0.01

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication